 Home > Biochemistry News > Biotechnology News > Positive progress in tumor electric field therapy for lung cancer Zai Lab owns rights in Greater China

Positive progress in tumor electric field therapy for lung cancer Zai Lab owns rights in Greater China

 Last Update: 2021-04-17
 Source: Internet
 Author: User

Tags

sunscreen fda approved

mycoplasma cell culture

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, Novocure announced that its Tumor Treating Fields (TTF) has made positive progress in a pivotal Phase 3 clinical trial for the treatment of patients with non-small cell lung cancer.

Tumor treatment electric field is a low-intensity alternating electric field, which can affect the movement of specific cell components during cell mitosis and disrupt mitosis.

This innovative treatment has been approved by the US FDA and used in combination with chemotherapy for the first-line treatment of unresectable locally advanced or metastatic malignant pleural mesothelioma.

This pivotal phase 3 clinical trial aims to evaluate the combination of tumor electric field therapy with immune checkpoint inhibitors or docetaxel, compared with immune checkpoint inhibitors or docetaxel monotherapy, in treatment level 4 ( stage 4) The effect in patients with non-small cell lung cancer.

Note: The original text has been deleted

Reference materials:

[1] Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.